Debiopharm Licenses SunRock Biopharma’s Anti-HER3/HER2 Antibody to Explore the Full Potential of Bispecific ADC Debio 2512
LAUSANNE, Switzerland & SANTIAGO DE COMPOSTELA, Spain–(BUSINESS WIRE)– Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company today announced having signed a license agreement for SunRock Biopharma’s...